TIDMPFZ

RNS Number : 6465G

Northern Trust Corporation

23 November 2015

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.       KEY INFORMATION 
 
Name of person dealing      Northern Trust Group 
 (Note 1) 
==========================  ==================== 
Company dealt in            Allergan Plc 
==========================  ==================== 
Class of relevant security  Ordinary Shares 
 to which the dealings 
 being disclosed relate 
 (Note 2) 
==========================  ==================== 
Date of dealing             (20th November 2015) 
==========================  ==================== 
 
   2.         INTERESTS AND SHORT POSITIONS 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 
                                          Long                Short 
===========================  ===================  ===================== 
                             Number          (%)   Number           (%) 
===========================  =======  ====  ====  =========  ====  ==== 
(1) Relevant securities      4,454,062 1.13 
===========================  ===================  ===================== 
(2) Derivatives (other 
 than options) 
===========================  ===================  ===================== 
(3) Options and agreements 
 to purchase/sell 
===========================  ===================  ===================== 
Total                        4,454,062 1.13 
===========================  ===================  ===================== 
 
 

* Note: The difference in holdings from yesterday and today not explained by transactions, can be explained by stock transfers of 71 securities out of the relevant accounts

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 
Class of relevant security:                Long                Short 
============================  ===================  ===================== 
                              Number          (%)   Number           (%) 
============================  =======  ====  ====  =========  ====  ==== 
(1) Relevant securities 
============================  ===================  ===================== 
 
  (2) Derivatives (other 
  than options) 
============================  ===================  ===================== 
 
  (3) Options and agreements 
  to purchase/sell 
============================  ===================  ===================== 
Total 
============================  ===================  ===================== 
 
 
   3.       DEALINGS (Note 4) 
   (a)      Purchases and sales 
 
 
  Purchase/sale            Number of relevant securities        Price per unit (USD) 
================  ======================================  ========================== 
      Buy                           16                           311.95 
================  ======================================  ========================== 
      Buy                           37                           312.14 
================  ======================================  ========================== 
      Buy                          204                           312.46 
================  ======================================  ========================== 
      Buy                          1110                          314.44 
================  ======================================  ========================== 
      Sell                         387                           312.46 
================  ======================================  ========================== 
      Sell                         170                           312.48 
================  ======================================  ========================== 
      Sell                         242                           314.58 
================  ======================================  ========================== 
      Buy                          200                           309.75 
================  ======================================  ========================== 
      Buy                           9                            314.44 
================  ======================================  ========================== 
 
   (b)      Derivatives transactions (other than options transactions) 
 
Product    Nature of transaction  Number of relevant   Price per 
 name,      (Note 6)               securities           unit 
 e.g. CFD                          (Note 7)             (Note 5) 
=========  =====================  ==================  ========== 
 
 
   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing, selling, purchasing or varying 
 
Product     Writing,      Number of       Exercise  Type,            Expiry  Option 
 name,       selling,      securities      price     e.g. American,   date    money paid/received 
 e.g. call   purchasing,   to which                  European                 per unit 
 option      varying       the option                etc.                     (Note 5) 
             etc.          relates (Note 
                           7) 
==========  ============  ==============  ========  ===============  ======  ==================== 
 
 
   (ii)      Exercising 
 
Product name,             Number of securities      Exercise price 
 e.g. call option                                    per unit (Note 
                                                     5) 
=================  ===========================  =================== 
 
 
   (d)      Other dealings (including transactions in respect of new securities) (Note 4) 
 
Nature of transaction         Details      Price per unit 
 (Note 8)                                   (if applicable) 
                                            (Note 5) 
=====================  ==============  ==================== 
 
 
   4.       OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant

securities to which any derivative referred to on this form is referenced. If none, this should be stated.

N/A

   Is a Supplemental Form 8 attached? (Note 9)                                            NO 
 
Date of disclosure             23(rd) November 2015 
============================  ===================== 
Contact name                  Paul Adair 
============================  ===================== 
Telephone number              020 7982 1236 
============================  ===================== 
If a connected EFM, name      N/A 
 of offeree/offeror with 
 which connected 
============================  ===================== 
If a connected EFM, state     N/A 
 nature of connection (Note 
 10) 
============================  ===================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ISEPKNDBQBDDODB

(END) Dow Jones Newswires

November 23, 2015 09:29 ET (14:29 GMT)

Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Pfizer.
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Pfizer.